Clinical trials: sponsored by Biogen
Multiple Sclerosis
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease…
- Trial name
- NCT00223457
- Testing
- Factors that influence compliance
- Where
- United States
- Volunteers
- 1,040 people
- Sponsor
- University of Texas Southwestern Medical Center
Chronic Plaque Psoriasis
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
An open-label, multicentre study to evaluate the efficacy and safety of one course of weekly intramuscular administration of Amevive in Taiwan patients with chronic plaque psoriasis
- Trial name
- NCT00422617
- Testing
- Alefacept (Amevive)
- Volunteers
- 40 people
- Sponsor
- Uni-Pharma
Psoriasis, Palmoplantaris Pustulosis
Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis
The purpose of this study is to determine if Alefacept is effective in the treatment of palmar plantar pustulosis.
- Conditions
- Psoriasis, Palmoplantaris Pustulosis, Pustular Psoriasis of Palms and Soles, Pustulosis Palmaris et Plantaris
- Trial name
- NCT00301002
- Testing
- Alefacept
- Where
- Canada
- Volunteers
- 15 people
- Sponsor
- The Guenther Dermatology Research Centre
Non-Hodgkin's Lymphoma
Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
The purpose of this study is to provide treatment for patients who have relapsed NHL or refractory NHL, and to determine the effectiveness and safety of the Zevalin and Rituxan regimens or Rituxan therapy alone on your disease.
- Trial name
- NCT00057343
- Testing
- Zevalin (ibritumomab tiuxetan), Rituxan (rituximab)
- Where
- 67 sites in United States
- Volunteers
- 400 people
- Sponsor
- Biogen
Relapsing Remitting Multiple Sclerosis
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis
The purpose of this study is to determine if using Avonex in combination with Zocor is a safe and effective therapy for subjects with relapsing remitting multiple sclerosis.
- Trial name
- NCT00242268
- Testing
- Simvastatin
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Alabama Neurology Associates, PC
Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
Rituximab is an antibody made in a laboratory. It binds to lymphoma cells and kills them. Treatment of recurrent B-cell lymphoma with rituximab may delay or prevent relapses.
- Trial name
- NCT00168740
- Testing
- rituximab
- Where
- 31 sites in United States, Canada
- Volunteers
- 150 people
- Sponsor
- Biogen